SCHEMBL258866

SCHEMBL258866

Cn1c(-c2ccc(-c3ccc4ccccc4c3)cc2)nc2c3cccnc3c3ncccc3c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 4/20 0.42
▸ CCR8 P51685 4/20 0.42
▸ CYP17A1 P05093 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ TLR7 Q9NYK1 1/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.38
▸ CCR5 P51681 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HTR2B P41595 1/20 0.37
▸ HTR5A P47898 1/20 0.37
▸ GRM1 Q13255 1/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ATP1A1 P05023 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14579763 0.89 CCR1 (0.43) CCR1CCR8TLR7L3MBTL1CCR5
SCHEMBL14579756 0.89 L3MBTL1 (0.47) CCR1CCR8TLR7L3MBTL1CCR5
SCHEMBL5486079 0.85 TLR7 (0.51) CCR1CCR8TLR7L3MBTL1CCR5
SCHEMBL14579757 0.85 CCR1 (0.46) CCR1CCR8TLR7L3MBTL1CCR5
SCHEMBL14579765 0.83 L3MBTL1 (0.41) CCR1CCR8TLR7L3MBTL1CCR5
SCHEMBL16692125 0.82 KDM4E (0.48) TLR7NPC1RAB9AESR1ESR2
SCHEMBL2150706 0.82 CYP11B2 (0.41) CCR1CCR8CYP17A1CYP19A1CYP11B1
SCHEMBL14579764 0.82 NPC1 (0.40) CCR1CCR8TLR7L3MBTL1CCR5
SCHEMBL2293902 0.79 CCR1 (0.46) CCR1CCR8L3MBTL1CCR5NPC1
SCHEMBL14579760 0.78 L3MBTL1 (0.47) CCR1CCR8CYP11B2TLR7L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 453 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2026-03-19 — — US claimed
US-11849598-B2 Organic light-emitting component having a light-emitting layer as part of a charge generation layer PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2023-12-19 — — US claimed
US-20220085338-A1 ORGANIC LIGHT-EMITTING COMPONENT HAVING A LIGHT-EMITTING LAYER AS PART OF A CHARGE GENERATION LAYER PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2022-03-17 — — US claimed
US-11056660-B2 Organic optoelectronic component and method for producing the same PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2021-07-06 — — US claimed
CN-107210364-B Aminophosphazene bases as n-type dopants in organic electronic products 西门子公司 2021-05-04 — — CN claimed
EP-3230295-B1 AMINO PHOSPHAZENE BASES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AG (DE) 2019-07-31 — — EP claimed
US-10361376-B2 Proazaphosphatranes as n-dopants in organic electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2019-07-23 — — US claimed
EP-3233873-B1 PROAZAPHOSPHATRANES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AG (DE) 2019-06-26 — — EP claimed
US-10230050-B2 Amino phosphazene bases as n-dopants in organic electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2019-03-12 — — US claimed
US-20180205028-A1 ORGANIC OPTOELECTRONIC COMPONENT AND METHOD FOR PRODUCING THE SAME DOLYA HOLDCO 5 LIMITED (IE) 2018-07-19 — — US claimed
US-20180019396-A1 Amino Phosphazene Bases As N-Dopants In Organic Electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2018-01-18 — — US claimed
US-20180006240-A1 Proazaphosphatranes As N-Dopants In Organic Electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2018-01-04 — — US claimed
US-9520570-B2 Organic electronic device and method for the production thereof OSRAM OLED GMBH (DE) 2016-12-13 — — US claimed
EP-2483945-B1 ORGANIC ELECTRONIC DEVICE AND METHOD FOR THE PRODUCTION THEREOF OSRAM OLED GMBH (DE) 2016-11-02 — — EP claimed
US-20150060794-A1 ORGANIC LIGHT EMITTING DEVICE AND MANUFACTURING METHOD THEREOF SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-05 — — US claimed
US-20120286253-A1 Organic Electronic Device and Method for the Production Thereof OSRAM OLED GMBH (DE) 2012-11-15 — — US claimed
US-12622170-B2 Fluorescent organic light emitting elements having high efficiency UDC Ireland (IE) 2026-05-05 — — US disclosed
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT PICTIVA DISPLAYS INTERNATIONAL LIMITED (IE) 2026-03-19 — — US disclosed
WO-2010079051-A1 SILYL AND HETEROATOM SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZO PHOSPHOLES AND THE APPLICATION THEREOF IN ORGANIC ELECTRONICS BASF SE (DE) 2010-07-15 — — WO disclosed
WO-2010040777-A1 SILOLES SUBSTITUTED WITH CONDENSED RING SYSTEMS AND USE THEREOF IN ORGANIC ELECTRONICS OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2010-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361376-B2 Proazaphosphatranes as n-dopants in organic electronics PNP, NUDT1, SLC29A1 CCR1 4395/4885CCR8 4206/4885CYP17A1 3066/4885
US-12622170-B2 Fluorescent organic light emitting elements having high efficiency TEAD1, EEF1D, TEAD2 CCR1 164/4885CCR8 1644/4885CYP17A1 1221/4885
US-20260082802-A1 ORGANIC ELECTRONIC COMPONENT AND METHOD FOR PRODUCING AN ORGANIC ELECTRONIC COMPONENT FLNA, FLNB, CDH1 CCR1 4767/4885CCR8 4565/4885CYP17A1 2300/4885
US-10230050-B2 Amino phosphazene bases as n-dopants in organic electronics PHOSPHO1, SLC29A1, NME2 CCR1 4577/4885CCR8 4696/4885CYP17A1 4403/4885
US-20180006240-A1 Proazaphosphatranes As N-Dopants In Organic Electronics PNP, NUDT1, SLC29A1 CCR1 4395/4885CCR8 4206/4885CYP17A1 3066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback